Publication | Open Access

Proteasome Inhibition in Multiple Myeloma: Head-to-Head Comparison of Currently Available Proteasome Inhibitors

Hematological MalignancyProteasome InhibitionOncologyMedicineMalignant Blood DisorderHematologyMultiple MyelomaPharmacotherapyHead-to-head ComparisonAnti-cancer AgentPharmacologyRadiation OncologyCancer ResearchHealth Sciences